Authors:
A
CharlotteBleasePhD
1✉EmailCharlotte.blease@uu.se CarolinaGarciaSanchezMSc
1 1PATH Research Group, Department of Women’s and Children’s HealthUppsala UniversityUppsalaSweden
2Centre for Primary Care and Health Services ResearchUniversity of ManchesterManchesterUK
3Centre for Health Informatics, Australian Institute for Health InnovationMacquarie UniversitySydneyNSWAustralia
4Clinical Psychology and Psychotherapy, Faculty of PsychologyUniversity of BaselBaselSwitzerland
5Clinical Psychology and Psychosomatics, Faculty of PsychologyUniversity of BaselBaselSwitzerland
Charlotte Blease PhD1, Anna Kharko PhD1,2, Carolina Garcia Sanchez MSc1, David Navarro PhD3, Brian McMillan PhD2, Jens Gaab PhD4, Cosima Locher PhD5, Enrico Coiera PhD3
Affiliations
1. PATH Research Group, Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
2. Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.
3. Centre for Health Informatics, Australian Institute for Health Innovation, Macquarie University, Sydney, NSW, Australia
4. Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel Switzerland
5. Clinical Psychology and Psychosomatics, Faculty of Psychology, University of Basel, Basel Switzerland
Corresponding author: Charlotte Blease, PhD, Charlotte.blease@uu.se
Tables/Figures:
Table 1. Respondent characteristics of GPs who are users and non-users of Ambient AI.
Table 2. Ambient AI scribes used by GPs.
Table 3. Workload and impact of ambient AI scribes on it.
Table 4. Example quotes for emerging categories.
Figure 1. Errors and medico-legal risks associated with ambient AI documentation.
Supplementary files:
Appendix 1. Survey.
Appendix 2. CROSS Checklist.
Appendix 3. Additional analyses.
Appendix 4. Raw data.
ABSTRACT
Abstract
Results: Of 1,003 respondents, 14% (n = 141) reported current use of ambient AI scribes, 39% (n = 396) intended to adopt them soon, and 46% (n = 466) had no plans to use them. Among users, Heidi Health predominated (86%). Most reported efficiency gains: 80% (n = 112) reported reduced time spent on documentation and 70% (n = 99) reduced cognitive load. Documentation quality was judged positively, with 55% (n = 78) rating outputs as better than standard notes. Errors were common but usually minor: 32% (n = 45) reported errors often/always, including 14% (n = 20) with significant–critical implications. Errors were most frequent in multi-party consultations (38%), complex histories (35%), and non-English encounters (31%). Consent practices varied: 63% (n = 89) routinely sought consent, with ≤ 10% of patients declining. Free-text responses (21% of users) highlighted benefits for workflow, alongside concerns about accuracy, ethics, and system integration.
KEY MESSAGES
What is already known on this topic
Ambient AI scribes are marketed as tools to ease documentation and reduce burnout, but evidence on real-world uptake and GP perspectives in the UK is sparse.
What this study adds
This survey shows early but growing adoption, with GPs reporting clear efficiency gains but also accuracy concerns, especially in complex and multilingual consultations.
How this study might affect research, practice or policy
A
Findings highlight the need for regulation, consistent consent practices, and prospective studies, including patient perspectives, to guide safe and equitable implementation.
A
A
A
A
INTRODUCTION
Ambient AI scribes, also referred to as ‘digital scribes’ [1] or ambient voice technology (AVT), are emerging tools designed to passively capture clinician–patient conversations and automatically generate documentation within electronic health records [2]. This is a rapidly expanding market which may reduce the documentation burden on clinicians, thereby addressing one of the major drivers of burnout in primary care [3].
Despite this promise, their use raises important challenges [
4,
5]. Concerns include accuracy and reliability of transcribed notes, risks of errors or omissions in documentation, medico-legal liability, patient consent, and the potential loss of nuance in clinical communication [
6].
A
Furthermore, biases in speech recognition and summarisation may result in systematic disadvantages for certain groups of patients, such as those with strong regional or foreign accents, or individuals with speech disorders. The rapid pace of product development also creates uncertainty about consistency, integration into existing record systems, and implications for professional practice and for regulation.
Although interest in ambient AI scribes is growing, there is little empirical evidence on how widely they are being adopted in frontline general practice and how they are perceived by clinicians who use them [7, 8]. Few studies have directly explored the lived experiences, uptake, and opinions of doctors regarding these tools [7]. Given the apparent interest and rapid adoption in primary care settings, this study seeks to fill that gap by examining general practitioners’ (GPs) use of, and attitudes toward, ambient AI scribes in the UK.
METHODS
Survey design and recruitment
A
We carried out a nationwide, anonymous, web-based mixed methods survey targeting GPs across the United Kingdom. Recruitment was via
Doctors.net.uk, a clinician engagement and marketing platform that hosts the largest professional community of UK doctors. Membership of
Doctors.net.uk is free of charge but requires verification with a valid General Medical Council (GMC) registration number. Participation was restricted to verified GPs. Platform authentication confirmed professional status, and access controls prevented multiple submissions. At the time of the study, the platform included 254,741 members, representing roughly two-thirds of the UK’s 379,208 registered physicians.
The survey was incorporated into Doctors.net.uk’s regular “Omnibus” series, which explores current medical topics and samples 1,000 clinicians each month, a size comparable to other healthcare workforce surveys [9]. The research team previously collaborated with the platform on similar GP surveys [10, 11].
Between 7 and 27 August 2025, invitations to participate were distributed through a combination of methods: (1) embedded adverts placed on members’ homepage dashboards, and (2) targeted email invitations to those who had opted in to receive research communications. During this period, 9,024 GPs logged into the Doctors.net.uk website while the survey was live. A stratified random sampling procedure was used to ensure national coverage. Regional stratification was based on demographic data from the GMC’s Data Explorer resource.
Survey instrument and administration
This survey follows the format of previous studies we have conducted into UK GPs’ experiences and opinions with AI tools [10, 11]. We devised an anonymous, approximately 5-minute questionnaire that defined “ambient AI scribes” for respondents as background systems that capture consultation dialogue and automatically generate documentation such as notes or referral letters in the electronic health record (see Appendix 1). A screening question ensured that only current users of ambient AI scribes proceeded with the survey; here we also asked whether GPs who had not used these tools intended to do so in the near future.
The instrument consisted of 8 core closed-ended questions, with some conditional follow-ups and a single free-text prompt. Items addressed which products were being used (multi-select, including examples such as Nuance DAX, Heidi Health, Suki AI, DeepScribe, Augnito, and Amazon HealthScribe), the frequency and clinical significance of transcription errors, how often such errors were corrected, and whether errors were more common in particular patient groups. Other questions covered medico-legal concerns, perceived changes in cognitive workload, burnout, time spent on documentation, overall note quality, and approaches to patient consent, including the proportion of patients who declined when consent was sought. Aside from the 8, core closed-ended questions, the survey included 7 demographic questions including about weekly working hours, and the average number of patients seen per day. The survey concluded with an optional free-text box inviting respondents to share additional reflections. All closed-ended questions were mandatory for submission, while the free-text question was optional.
Prior to launch, the instrument was piloted with five UK-based GPs to ensure clarity and usability. The final survey was designed to take 3–5 minutes to complete.
A
Survey design and reporting followed the Checklist for Reporting Of Survey Studies (CROSS) guidelines (see Appendix 2).
Ethical considerations
A
A
The study protocol was approved by the Faculty of Psychology Ethics Committee at the University of Basel, Switzerland (Nr 017-25-1).
A
Participants were provided with study information and gave informed consent electronically before participation. The survey was hosted on a secure server maintained by
Doctors.net.uk. All responses were anonymised and encrypted prior to transfer for analysis. Personal identifiers, including email addresses, were removed before data handling. The study complied with the EU General Data Protection Regulation.
Quantitative component
Participant characteristics and responses to survey opinion items were summarised through descriptive statistics. To analyse whether users and non-users of ambient AI scribes differed in gender, age, role, or practice size, a chi-square of independence test was carried out for each variable. If significant, it was followed by a post-hoc two-proportion z-test, where one variable level was tested against all others. Bonferonni-adjusted p-value was used. Given our non-random sample, to analyse whether differences with GPs in the GMC Registry, a chi-square goodness-of-fit test was used. Significance levels were pre-set to p < .05 for all tests. Analyses were carried out by AK in JASP (v0.95.1.0) and (v2.6.2). Tables and figures were created by AK.
Qualitative component
To capture richer perspectives, the survey included a single optional free-text item: “Please add any comments about the topic or the survey (1–2 brief comments).” Free-text responses were cleaned to remove trivial entries (e.g., “none,” “N/A”). Due to limitations with the data set, full inductive coding was not applicable. CB reviewed the data, developed descriptive codes, and iteratively refined coding decisions through discussion. Where responses contained multiple ideas, multiple codes were assigned. First-order codes were then grouped into higher-order categories to summarise recurrent patterns. This process was also independently carried out by GC, and through discussions, decisions were reached.
RESULTS
Quantitative analysis
Of the 2,855 who received an email invitation, 62% (n = 1,776) opened it, 38% (n = 676) clicked on the survey link, and 21% (n = 601) completed the survey. This resulted in a response rate of 21% among the invited sample (calculated as 601 ÷ 2,855 × 100). A further 402 responses came from respondents who accessed the survey via the Doctors.net.uk homepage; however, a denominator was not recorded. This resulted in a sample of 1,003 GPs. Of them, 46% (n = 466) reported that they neither used ambient AI scribes nor intended to in the near future, 39% (n = 396) reported that they were not currently using them but intended to do so, and 14% (n = 141) reported they used these tools. In the whole sample, half were women (n = 503) and nearly half were aged 35 to 45 years old (45%, n = 452), see Table 1. The sample differed from the GMC Registry on gender: there were significantly fewer women in our sample, χ2(1,984) = 19.38, p < .001, Cramer’s V = .14, but did not differ on regional distribution, see Appendix 3.
Table 1
Respondent characteristics of GPs who were users and non-users of Ambient AI.
| | Users (n = 141) | Non-users (n = 862) | Whole sample (N = 1,003) |
|---|
Gender | | | |
|---|
Woman | 64 (45.4%) | 439 (51%) | 503 (50.1%) |
Man | 74 (52.5%) | 407 (47.2%) | 481 (48%) |
Other | — | 1 (.1%) | 1 (0.1%) |
Preferred not to say | 3 (2.1%) | 15 (1.7%) | 18 (1.8%) |
Age | | | |
35 years or younger | 15 (10.6%) | 88 (10.2%) | 103 (10.3%) |
36–45 years | 62 (44%) | 287 (33.3%) | 349 (34.8%) |
46–55 years | 50 (35.5%) | 321 (37.2%) | 371 (37%) |
56 years or older | 14 (9.9%) | 166 (19.3%) | 180 (17.9%) |
Role | | | |
GP Partner or Principal | 76 (53.9%) | 350 (40.6%) | 426 (42.5%) |
Salaried GPs | 52 (36.9%) | 332 (38.5%) | 384 (38.3%) |
Locum GPs | 7 (5%) | 146 (17%) | 153 (15.3%) |
GP Registrar | 6 (4.3%) | 34 (3.9%) | 40 (4%) |
GP practice size | | | |
Up to 5,000 patients | 6 (4.3%) | 105 (12.2%) | 111 (11.1%) |
5,001–7,500 patients | 19 (13.4%) | 131 (15.2%) | 150 (15%) |
7,501–10,000 patients | 28 (19.9%) | 175 (20.3%) | 203 (20.2%) |
10,001–12,500 patients | 24 (17%) | 148 (17.2%) | 172 (17.1%) |
12,501 patients or more | 64 (45.4%) | 303 (35.1%) | 367 (36.6%) |
| Note: Percentages are calculated based on column total. |
Fewer GPs aged ≥ 56 reported using Ambient AI (–9%, adjusted p = .03) see Appendix 3. Use did not differ by gender (χ²(1,984) = 1.48, p = .224), but significant differences were observed for age (χ²(3,1003) = 9.97, p = .019, Cramer’s V = .10), role (χ²(3,1003) = 16.55, p < .001, Cramer’s V = .13), and practice size (χ²(4,1003) = 10.6, p = .031, Cramer’s V = .10) (see Appendix 3). Users were more likely to be GP Partners or Principals (+ 13%, adjusted p = .012) and less likely to be Locum GPs (-12%, adjusted p = .001). Users were also less likely to report working in smaller practices with up to 5,000 patients (-8%, adjusted p = .027).
Heidi Health was the most popular AI scribe used by 86% of GPs, see Table 2. Two thirds of GPs (63%, n = 89) reported that they routinely obtained consent from patients before using AI during the consultation. When asked to estimate how many patients declined consent, most GPs reported it to be 10% of all patients or fewer (89%, n = 40), see Appendix 3.
Table 2
Ambient AI scribes used by GPs.
| | Users (n = 141) |
|---|
Heidi Health | 122 (86.5%) |
Accurx Scribe | 18 (12.8%) |
i-Scribe | 2 (1.4%) |
Suki AI | 1 (.7%) |
DeepScribe | 1 (.7%) |
Other | |
Anima Scribe | 3 (2.1%) |
Lexacom Echo | 2 (1.4%) |
Meta AI | 1 (.7%) |
RingCentral AI Transcription | 1 (.7%) |
Tandem AI | 1 (.7%) |
Tortus | 1 (.7%) |
Unspecified | 1 (.7%) |
| Note: Scribes that were listed but received no votes: Augnito Spectra, Dragon Ambient eXperience (DAX), Heparin Write, HepianScribe, Lyrebird Health, Tali.AI. The survey item was multiple-choice; total count exceeds user count. |
As seen in Table 3, a third of respondents reported working 30 to 40 hours per week, and most (85%, n = 122) reported seeing at least 26 patients daily. 27% (n = 38) reported experiencing varying degrees of burnout. Among respondents, most reported that ambient AI decreased cognitive workload during consultation (70%, n = 99) and decreased time spent creating documentation (80%, n = 112).
Table 3
Workload and impact of ambient AI scribes on it.
| | Users (n = 141) |
|---|
Hours worked per week | |
|---|
Fewer than 10 hrs | 2 (1.4%) |
10–20 hrs | 16 (11.3%) |
20–30 hrs | 28 (19.9%) |
30–40 hrs | 45 (31.9%) |
40–50 hrs | 35 (24.8%) |
More than 50 hrs | 15 (10.6%) |
Patients seen per day | |
0 | — |
1–5 | 1 (.7%) |
6–10 | 4 (2.8%) |
11–15 | 5 (3.5%) |
16–20 | 10 (7.1%) |
21–25 | 29 (20.6%) |
26–30 | 63 (44.7%) |
31 or more | 29 (20.6%) |
Self-rated level of burnout | |
I enjoy my work. I have no symptoms of burnout. | 21 (14.9%) |
Occasionally I am under stress, but I don’t feel burned out. | 82 (58.2%) |
I am definitely burning out and have one or more symptoms of burnout. | 24 (17%) |
The symptoms of burnout that I’m experiencing won’t go away. | 9 (6.4%) |
I feel completely burned out and often wonder if I can go on. | 5 (3.5%) |
Impact of Ambient AI on cognitive workload | |
Significantly decreased | 28 (19.9%) |
Somewhat decreased | 71 (50.4%) |
No change | 39 (27.7%) |
Somewhat increased | 3 (2.1%) |
Significantly increased | — |
Impact of Ambient AI on time spent on documentation | |
Greatly decreased | 42 (29.8% |
Slightly decreased | 70 (49.6%) |
No change | 18 (12.8%) |
Slightly increased | 10 (7.1%) |
Greatly increased | 1 (.7%) |
| Note: Refer to Appendix 1 for the exact wording of the survey items. |
When contemplating the quality of the AI-generated texts, half of the GPs (55%, n = 78) perceive it as ‘Good (better than standard medical documentation, requiring minimal revision)’, see Appendix 3. At the same time, almost half of GPs (44%) reported that they find errors in 10 to 30% of the documentation and a similar proportion (41%) correct nearly all generated documentation with 16% reporting correcting 16% or less, see Fig. 1. Further evaluating the errors, half (52%, n = 73) considered them ‘insignificant’ or ‘minor’ and not affecting patient care. Still, half (50%, n = 70) were ‘slightly concerned’ about the medico-legal risks associated with using AI scribes. Consultations with specific patient groups generated more ambient AI errors, e.g. when there are multiple patients or carers present in the room (38%, n = 53), and patients with complex medical histories (35%, n = 49).
Qualitative analysis
A
Of the 141 respondents, 29 (21%) provided free-text comments, generating a total of 689 words after data cleaning. Most entries were concise, often comprising short phrases or 1–3 sentences. Through inductive coding and iterative analysis, four overarching categories of views on AI scribe use in general practice were identified: (1) Perceived benefits in workflow and patient care; (2) Accuracy and reliability concerns; (3) Ethical and professional considerations; and (4) Future expectations and system-level challenges. Quotes are anonymised and presented verbatim; participant number, gender, and age are in parentheses. Overall, GPs’ views captured a blend of enthusiasm and caution. While AI scribes were recognised as valuable in alleviating workload and enhancing patient focus, concerns about accuracy, professional identity, and system integration underscored the need for ongoing refinement and support.
Table 4
Example quotes for emerging categories.
Category | Description | Example quotes |
|---|
#1 | Perceived benefits in workflow and patient care | “helpful and time saving” [#131, F, 36 to 45] “very useful” [#54, M, 46 to 55] “concentrate on the patient rather than the keyboard” [#133, M, 56 or over] |
#2 | Accuracy and reliability concerns | “miss important bits” [#67, M, 56 or over] “It makes every consult look the same which makes the review of notes less meaningful” [#49, F, 56 or over] “The notes don’t capture the uncertainty and art of general practice” [#10, F, 36 to 45] |
#3 | Ethical and professional considerations | “I don't ask consent because it is just a scribing tool. I have never historically asked consent to use a Dictaphone to dictate patient referral letters either - there is no difference” [#73, F, 45 to 55] “there are notices throughout the practice, and on consulting room doors and consulting room desks indicating that AI scribes are being used” [#91, M, 56 or over] “…directly as a result of this being pulled as a tool to support GPs I am likely to have to quit working as a GP in the NHS” [#15, M, 46 to 55] |
#4 | Future expectations and system-level challenges | “a step in the right direction” [#31, M, 36 to 45] “It is great but needs vigilant monitoring to correct errors” [#15, M, 46 to 55] “I expect it will improve further and we should embrace it” [#66, F, 35 to 45] |
| Note: Example quotes chosen |
DISCUSSION
Summary of main findings
Administered in August 2025, this exploratory online survey (N = 1,003) is, to our knowledge, the largest UK study of GPs to assess current use and intended adoption of ambient AI scribes. Almost one in seven had used these tools (141/1,003; 14%), with a further 39% intending to adopt them soon (396/1,003); among users, Heidi Health predominated (121/141; 86%). Error detection was common but usually not severe: 32% (45/141) reported errors often or always, yet 86% (121/141) judged them insignificant-moderate, and 14% (20/141) significant–critical; 57% (81/141) corrected errors often or almost always. Perceived error risk was highest in multi-party consultations (38%), complex histories (35%), non-English primary language (31%), speech impairment (21%), noisy environments (20%), and cognitive impairment (13%) - patterns that may entrench the inverse care law, with those most in need again underserved.
Workload signals were favourable: 80% (112/141) reported reduced time spent on documentation (30% greatly; 50% slightly) and 70% (99/141) reported decreased cognitive load (20% significant; 50% somewhat); 28% noted no change and only 2% an increase. Medicolegal concerns were limited − 9% (13/141) were very/extremely concerned. Consent practices varied: 63% (89/141) reported routinely seeking patient consent; among these, 89% (79/89) said ≤ 10% of patients declined. Overall, as supported by the free text comments, GPs reported meaningful efficiency gains alongside manageable, though non-trivial, error, equity, and governance concerns.
Comparison with prior work
Our findings align with a qualitative study of 22 pilot physicians showing reduced documentation burden and cognitive load, but recurring barriers in non-English encounters [12]. They also accord with a US pre–post study in ambulatory care reporting meaningful reductions in clinician burnout and signs of improved professional fulfilment with ambient AI [13]. Together, the evidence indicates efficiency and well-being gains alongside typically low-severity errors, with weaker performance in multilingual and complex consultations.
Clinicians in our sample judged ambient AI scribes to improve documentation quality, even while acknowledging detectable errors. Notably, most errors were rated insignificant–moderate, with only a minority judged significant–critical. This sits alongside prior UK GP survey evidence in which roughly 60% anticipated that patients would find significant errors in their records [14], and US patient data showing that 1 in 5 note-readers reported a mistake and 40% of those considered it serious [15]. Against that backdrop, our pattern of responses suggests that, while errors persist, the error burden with ambient AI may be lower than with prevailing documentation approaches - though direct evaluations are needed to confirm this.
Beyond this, our own recent studies have documented an uptick in the availability and use of generative AI tools in clinical settings in the UK [10, 11]; ambient AI scribes appear to be part of this wider diffusion trend.
In April this year, NHS England (NHSE) issued guidance on the use of digital scribes in clinical settings [16]. This guidance places key responsibilities on users of this technology, namely that they need to: 1) assign a clinical safety officer to identify potential risks, 2) conduct a Data Protection Impact Assessment, 3) ensure the tool is appropriately integrated into existing systems, 4) ensure the tool meets existing data security and medical device regulations, and that staff are appropriately trained, and 5) implement ongoing monitoring of the tools performance [16]. Due to concerns about patient safety, NHSE’s chief clinical information officer wrote to NHS organisations in June this year to warn that staff must immediately stop using tools that had not been registered as a class I medical device with the UK’s Medicines and Healthcare Products Regulation Agency (MRHA) [17]. This letter stated that a national plan to standardise AVT deployment in England was being developed, and that further guidance would be published to ensure automatic deletion of patient data acquired by AVT systems [17].
Similar warnings about avoidance of use of unregulated generative AI have been issued by health departments in Australia [18]. The Australian professional regulator Ahpra also explicitly embeds seeking informed patient consent prior to using a scribe in its core professional code of conduct for clinicians [19]. However, it is still unclear whether clinicians in the UK are obligated to seek patient consent for the use of ambient AI scribes [16]. In addition to consent requirements, current regulation - both in the UK and Australia - still places the responsibility of keeping the record and ensuring its accuracy on the responsible clinician and not on the tools themselves. Users need to be aware that the use of AI scribes does not modify this, and they are still responsible from a legal point of view for accountability and liability purposes.
Strengths and limitations
This exploratory study delivers a timely UK snapshot of GP experience with ambient AI scribes. To our knowledge, it is the largest survey to date (N = 1,003; August 2025), capturing both current users and near-term adopters. However, the study has several limitations. The convenience, self-selected online sample limits generalisability and may be compromised by selection and non-response bias; all measures are self-report rather than linked to objective metrics. The modest sample of current users also limits power to explore determinants of uptake and precludes robust subgroup analyses. Outcomes were also self-reported; we lacked objective or independent measures of error rates and workflow impact.
As products evolve rapidly, these findings may date quickly, and ongoing, stratified UK sampling of clinicians is needed to track adoption and experiences with these tools. We recommend that future work should be prospective and multi-site and encompass objective workflow and safety metrics. We also strongly recommend that research be conducted into patients’ perspectives on the acceptability of these tools, including current consent processes.
CONCLUSION
This convenience sample survey of UK GPs provides the largest snapshot to date of current and intended use of ambient AI scribes in frontline practice. While uptake remains limited (14%), a further 39% of GPs anticipate near-term adoption, underscoring the rapid diffusion of these technologies. Users reported substantial gains in efficiency, with most experiencing reductions in both time spent on documentation and cognitive load. Importantly, perceived errors were typically minor, though a non-trivial proportion were considered clinically significant, and concerns were heightened in complex and multilingual consultations. These patterns highlight the dual potential of ambient AI scribes: to alleviate workload and improve documentation quality, but also to exacerbate inequities and introduce medico-legal risk if governance is weak.
A
Clear national regulation, robust safety monitoring, and consistent consent practices are urgently needed to ensure safe, equitable deployment. Prospective, multi-site research incorporating objective workflow and safety metrics—as well as patient perspectives—will be crucial to determine the long-term role of ambient AI in primary care.
Data Availability
The datasets generated during and/or analyzed during the current study are available in a supplementary file (see Supplementary File 4).
A
Acknowledgments
The authors thank Nicola Miles for support in the administration of this survey, and the GPs who offered feedback on a draft of the survey.
A
Author Contributions
CB, DN & EC conceptualized the study. CB, CL, JG conducted data collection. CB, CG & AK conducted data analysis. CB drafted the manuscript. All authors reviewed and approved the final version.
References
1.Coiera E, Kocaballi B, Halamka J et al (2018) The digital scribe. NPJ Digit Med 1:58
2.Haberle T, Cleveland C, Snow GL et al (2024) The impact of nuance DAX ambient listening AI documentation: a cohort study. J Am Med Inform Assoc 31:975–979
3.Wray J, Oldham G, Gough P et al Time to Care: The Value of AI-Powered Ambient Voice Technology Across Diverse Clinical Settings
4.Blease C, John Torous (2023) ChatGPT and mental healthcare: balancing benefits with risks of harms. BMJ Ment Health 26:e300884. 10.1136/bmjment-2023-300884
5.Blease C (2024) Open AI meets open notes: surveillance capitalism, patient privacy and online record access. J Med Ethics 50:84–89
6.Ha E, Choon-Kon-Yune I, Murray L et al (2025) Evaluating the Usability, Technical Performance, and Accuracy of Artificial Intelligence Scribes for Primary Care: Competitive Analysis. JMIR Hum Factors 12:e71434
7.Wray J, Oldham G, Gough P et al Time to Care: The Value of AI-Powered Ambient Voice Technology Across Diverse Clinical Settings
8.Ma SP, Liang AS, Shah SJ et al (2025) Ambient artificial intelligence scribes: utilization and impact on documentation time. J Am Med Inform Assoc 32:381–385
9.Thornton N, Binesmael A, Horton T et al (2024) AI in health care: what do the public and NHS staff think?
10.Blease C, Garcia Sanchez C, Locher C et al (2025) Generative Artificial Intelligence in Primary Care: Qualitative Study of UK General Practitioners’ Views. J Med Internet Res 27:e74428
11.Blease CR, Locher C, Gaab J et al (2024) Generative artificial intelligence in primary care: an online survey of UK general practitioners. BMJ Health Care Inf. ;31
12.Shah SJ, Crowell T, Jeong Y et al (2025) Physician perspectives on ambient AI scribes. JAMA Netw Open 8:e251904–e251904
13.Misurac J, Knake LA, Blum JM (2025) The Effect of Ambient Artificial Intelligence Notes on Provider Burnout. Appl Clin Inf 16:252–258. 10.1055/a-2461-4576
14.Blease CR, Kharko A, Dong Z et al (2024) Experiences and opinions of general practitioners with patient online record access: an online survey in England. BMJ open 14:e078158
15.Bell SK, Delbanco T, Elmore JG et al (2020) Frequency and Types of Patient-Reported Errors in Electronic Health Record Ambulatory Care Notes. JAMA Netw Open 3:e205867–e205867
16.NHS England (2025) Guidance on the use of AI-enabled ambient scribing products in health and care settings. NHS Engl. https://www.england.nhs.uk/long-read/guidance-on-the-use-of-ai-enabled-ambient-scribing-products-in-health-and-care-settings/
17.Moberly T (2025) Doctors must stop using unregistered AI scribe tools, says NHS England
18.Safer Care Advisory (2023) Health service use of unregulated Artificial Intelligence (AI). Melbourne, Victoria, Australia
19.Australian Health Practitioner Regulation Agency (2025) Meeting your professional obligations when using Artificial Intelligence in healthcare. Aphra. https://www.ahpra.gov.au/Resources/Artificial-Intelligence-in-healthcare.aspx (accessed 1 October